725 results on '"Stevenson, John C."'
Search Results
52. Coronary heart disease and menopause management: The swinging pendulum of HRT
53. G. I. M. Swyer
54. David McKay Hart, MD, FRCS (Glasgow), FRCOG
55. David McKay Hart MD, FRCS (Glasgow), FRCOG (1936–2020)
56. The metabolic basis for the effects of HRT on coronary heart disease
57. Hormone replacement therapy: Review, update, and remaining questions after the women’s health initiative study
58. List of Contributors
59. Bone and Calcium Metabolism
60. Effects of tibolone or continuous combined oestradiol/norethisterone acetate on glucose and insulin metabolism
61. Primary prevention of cardiovascular disease with HRT
62. Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists
63. Bisphosphonates and Atypical Femoral Shaft Fractures
64. Cardiovascular Complications in Patients with Turner’s Syndrome
65. Progestogens as a component of menopausal hormone therapy: the right molecule makes the difference
66. Efficacy and safety of a low-dose continuous combined hormone replacement therapy with 0.5 mg 17β-estradiol and 2.5 mg dydrogesterone in subgroups of postmenopausal women with vasomotor symptoms
67. Early menopause is associated with increased risk of arterial hypertension: A systematic review and meta-analysis
68. Biochemical changes
69. Conclusions
70. Management
71. Bone structure
72. An Atlas of Osteoporosis
73. Pathophysiology
74. Epidemiology
75. Diagnosis
76. Interventions for Osteoporosis
77. Contributors
78. Coronary heart disease in women
79. Does estrogen therapy reduce coronary artery calcification in postmenopausal women?
80. Randomized trial of effects of continuous combined HRT on markers of lipids and coagulation in women with acute coronary syndromes: WHISP Pilot Study
81. HRT, osteoporosis and regulatory authorities Quis custodiet ipsos custodes?
82. Hormone Replacement Therapy and the Cardiovascular System: Nonlipid Effects
83. Progestogens as a component of menopausal hormone therapy: The right molecule makes the difference
84. Preliminary evaluation of a new ultrasound bone densitometer
85. Inflammation markers and erythrocyte sedimentation rate but not metabolic syndrome factor score predict coronary heart disease in high socioeconomic class males: the HDDRISC study
86. Prevention of Osteoporosis: Current Recommendations
87. Randomized trial of effect of transdermal continuous combined hormone replacement therapy on cardiovascular risk markers
88. Insulin resistance: syndrome or tendency?
89. Role of oestrogen in the development of osteoporosis
90. The Effects of Oral Desogestrel and Estradiol Continuous Combined Hormone Replacement Therapy on Serum Lipids and Body Composition in Postmenopausal Women
91. Effects of oestrogen–only and oestrogen–progestogen replacement therapy upon circulating angiotensin I–converting enzyme activity in postmenopausal women
92. Effects of tibolone or continuous combined oestradiol and norethisterone acetate on lipids, high‐density lipoprotein subfractions and apolipoproteins in postmenopausal women in a two‐year, randomized, double‐blind, placebo‐controlled trial
93. Is there a role for menopausal hormone therapy in a woman with increased lipoprotein (a) concentrations?
94. Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women
95. Cardiovascular Risk in Perimenopausal Women
96. Premature Ovarian Insufficiency and Long-Term Health Consequences
97. BMS consensus statement for primary prevention of coronary heart disease in women
98. EMAS position statement: Predictors of premature and early natural menopause
99. Independent relationships between bone mineral density, regional body fat and insulin sensitivity in white males
100. Contributors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.